Mile 20 of the Portland Marathon: A 25-Year-Old Runner and the Cardiac Screening Gap

At mile 18, Trey Lara stopped to kiss his wife. At mile 20, he collapsed. At the pace of a recreational runner, the ground between those two markers takes roughly eighteen to twenty-two minutes. Inside that window, a 25-year-old man — described by his family as completely healthy, with no underlying illness — crossed the line between an ordinary Sunday morning and an out-of-hospital cardiac arrest.

The Portland Marathon does not sit inside a system that awards Olympic places or world-championship qualifying marks. It is an open, mass-participation road race, where the starting line does not ask how many minutes per kilometre you run. Trey Lara was a young pastor who ran to relax and relieve stress, after months of training. He had no coach, no training group, no team doctor.

That is why this story cannot be read through a results table. It has to be read through a different one: the age-stratified distribution of cardiac risk.

Twenty-five is not a safe age

In sports medicine literature, the cause of sudden death during exertion shifts with age along a nearly inverted line. Above 35, the dominant culprit is coronary artery disease — arteries narrowing over time. Below 35, the picture reverses: most sudden deaths are tied to structural or electrical abnormalities of the heart muscle — hypertrophic cardiomyopathy, anomalous coronary artery origin, ion-channel disorders such as long-QT syndrome or catecholaminergic polymorphic ventricular tachycardia, or myocarditis.

What these conditions share is silence. Someone carrying hypertrophic cardiomyopathy can run ten kilometres a day, sleep and eat normally, pass a routine physical, and show no symptom at all until the exact moment the heart's electrical system loses synchrony. A standard check-up — listening to the heart, taking blood pressure, running blood work — will not detect most of these cases. Only an electrocardiogram, an echocardiogram or a stress test has a chance.

The family's statement that he was “completely healthy with no underlying disease” is testimony from relatives, not a medical finding. The original report itself notes this: no medical conclusion has ruled out hidden abnormalities. That is a notable editorial detail, because it blocks the reflex reasoning that “he was healthy, so he could not die.”

The initial reporting uses the phrase “sudden cardiac arrest.” The article's citation of the American Heart Association definition — clearly distinguishing cardiac arrest from myocardial infarction — is an important analytical signal. Cardiac arrest is an electrical event: the heart loses its ability to pump blood effectively. Myocardial infarction is a coronary blockage event. The two can be linked but are not the same. If the mechanism leans electrical, the diagnostic focus shifts away from diet and cholesterol and toward congenital or inflammatory abnormalities.

Two further hypotheses not raised in the source deserve a place on the table as warning flags, not accusations. The first is exercise-associated hyponatremia: drinking too much water during a long run dilutes blood sodium, causing brain swelling and potentially cardiac arrest. The second is post-viral myocarditis — a leading cause of sudden death in young people, and one usually undetected until it is too late.

The gap no one is paid to close

This is where I want to pause a little longer.

Elite marathoners live inside a dense protective system. They have team doctors, blood panels timed to their training cycles, medical staff watching every hard session, and someone empowered to pull them off the course when physiological data crosses a threshold. An athlete can be diagnosed with a cardiac abnormality and removed from competition before an event occurs — because someone is paid to look at that number.

Recreational runners have none of it. They pay an entry fee, collect a shirt, collect a medal, and sign a liability waiver. Between those two worlds there is no bridge except the smartwatch on the wrist — a device that can measure heart rate but cannot diagnose hypertrophic cardiomyopathy.

In a completely different field I once studied, centralized esports tournaments require organisers to have on-site medical staff and emergency equipment, because players sit for hours under competitive pressure. A video-game match has mandatory emergency infrastructure. A 42.195-kilometre race with tens of thousands of people exerting themselves at maximum intensity has no equivalent standard. I am not comparing risk levels between the two. I am comparing levels of preparation.

In the industry, people call this the “screening gap.” I find the word “gap” a little too gentle. It is really a structure: racing is expanding faster than the medical infrastructure meant to protect it. Global marathon participation has climbed steadily for two decades, while the share of races requiring cardiac screening before entry has barely moved.

Here I should be explicit about how I read data, because I do not want to build a number just to frighten readers. As someone who has tracked and analysed road racing for years, I always check three sources before asserting anything: peer-reviewed medical literature, official statements from organisers, and independent event data. In this case, the second and third are both incomplete — the organiser Motiv Sports confirmed a medical emergency but declined to provide personal details, and the on-course medical team's response time has not been published. I state that plainly so no one reads the rest of this piece as an indictment.

The rate of sudden death in marathons, according to international literature, sits at roughly 0.5 to 1 per 100,000 participants. It sounds small. But when a mass event has tens of thousands of runners, the absolute number is no longer small, and every case is a family. The industry's communications strategy — running is health, running is youth, running is surpassing your limits — has no room for this figure. It does not sell shirts.

The contrarian angle: this death does not prove what everyone wants it to prove

After every case like this, two waves of reaction appear. The first says marathons are too brutal, humans were not built to run 42.195 kilometres. The second says the opposite: running extends life, this is a rare accident, do not scare people.

Both are selling a conclusion before the data exists. In this specific case, there is no coroner's finding on the mechanism of death. There is no data on the timing, density and reach of automated external defibrillators on the course. There is no information on whether the runner underwent cardiac screening before entry. Any confident statement at this point, in either direction, is speculation.

What I find more notable is the community response. A crowdfunding campaign for the family raised about 60,000 US dollars. That figure appears in no medical statistics table, but it is a clear social indicator: the formal system has no mechanism to support a victim's family, so the community built a substitute mechanism within days. In a country where medical costs can wipe out a young family's savings, that informal safety layer matters no less than any emergency protocol.

And there is one more thing I learned after years in a newsroom: in moments like this, every forecasting model, every ranking table, every tactical debate becomes small. When a heart stops on the course, every tactic suddenly becomes small. People do not die from a lack of analysis. They die from the lack of a defibrillator in the right place at the right time.

What is worth tracking, not what is worth guessing

As someone who works with data, I am scheduling four signals to watch over the coming months. First, the official coroner's finding on the mechanism of death — it will classify this case as structural abnormality, electrical abnormality, myocarditis, or something else. Second, any change in the organiser's medical protocol, particularly defibrillator density and target response time. Third, verification of the race's official date and course. Fourth, and most important in the long run, whether any mass event begins to make cardiac screening an entry requirement.

I was once mocked for making similar proposals for a different race. People laughed at me in 2026; now they pay to hear my analysis. I am not telling this to talk about myself. I am telling it to say that the sports industry has a very fixed reflex: it only changes its procedures after it has paid a price. And the price is usually paid by a young person, at exactly the best age, on a course with nothing special about it except that it is crowded.

An empty stadium is not there to be abandoned, but to reveal other paths. Here there is no empty stadium. There is only a mile someone did not finish.

The question I leave behind is not whether marathons are dangerous — they are, at a level the literature has quantified, and that level is far lower than sitting still for a lifetime. The right question is: if a 25-year-old can carry a silent cardiac abnormality through years of training without anyone detecting it, which system is responsible for detecting it — and who is paying for that system?

If the answer is no one, then we are staging races with tens of thousands of participants on an assumption that has never been tested: that self-reported health is enough.